New Covenant Trust Company, N.A. Tg Therapeutics, Inc. Transaction History
New Covenant Trust Company, N.A.
- $99.4 Million
- Q1 2024
A detailed history of New Covenant Trust Company, N.A. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, New Covenant Trust Company, N.A. holds 556 shares of TGTX stock, worth $11,069. This represents 0.01% of its overall portfolio holdings.
Number of Shares
556Holding current value
$11,069% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
269Shares Held
87.7MCall Options Held
2.72MPut Options Held
1.74M-
Vanguard Group Inc Valley Forge, PA13.5MShares$270 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.8MShares$216 Million0.0% of portfolio
-
State Street Corp Boston, MA7.8MShares$155 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.48MShares$69.4 Million0.02% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.33MShares$66.2 Million0.06% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $2.89B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...